Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
411
-
Total 13F shares, excl. options
-
169,058,166
-
Shares change
-
+10,117,794
-
Total reported value, excl. options
-
$14,840,823,389
-
Value change
-
+$900,396,515
-
Put/Call ratio
-
1.47%
-
Number of buys
-
211
-
Number of sells
-
-172
-
Price
-
$87.78
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q1 2017
490 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q1 2017.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 411 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 169,058,166 shares
of 193,539,047 outstanding shares and own 87.35% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (19,643,433 shares), VANGUARD GROUP INC (13,702,404 shares), BlackRock Inc. (11,065,452 shares), JENNISON ASSOCIATES LLC (9,894,605 shares), FMR LLC (9,703,010 shares), SANDS CAPITAL MANAGEMENT, LLC (8,972,405 shares), PRIMECAP MANAGEMENT CO/CA/ (8,712,268 shares), BAKER BROS. ADVISORS LP (4,806,483 shares), STATE STREET CORP (4,001,529 shares), and Invesco Ltd. (3,633,198 shares).
This table shows the top 411 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.